Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)

Sponsor
Ohio State University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02544074
Collaborator
Brain Test, Inc. (Industry)
69
1
95.3
0.7

Study Details

Study Description

Brief Summary

The Self-Administered Gerocognitive Examination (SAGE) is a valid and reliable cognitive assessment tool used to identify both Mild Cognitive Impairment (MCI) and early dementia. SAGE's self-administered feature, pen and paper format, and four equivalent interchangeable forms allows it to be given in almost any setting, does not require any staff time to administer and makes it practical to rapidly screen large numbers of individuals in the community or in their home.This trial is being conducted to study the validity of SAGE in a digital format (eSAGE) for cognitive screening.

The investigators will analyze the data to learn the correlations between eSAGE and gold standard neuropsychological testing designed to differentiate normal cognition from MCI and early dementia. The investigators will also find out whether the paper (SAGE) and electronic (eSAGE) versions of SAGE could be used interchangeably or not.

Addendum:

The eSAGE was previously validated in an earlier stage of this trial. It was initially designed for tablet use and the exact same test has recently been formatted for smartphone use.

This addendum is being conducted to study the validity of the smartphone eSAGE compared to the tablet eSAGE for cognitive screening.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: neuropsychological testing
  • Behavioral: eSAGE testing

Detailed Description

Participants will be recruited based on their eSAGE scores and evaluated with neuropsychological testing and medical history to determine their status as normal, mild cognitive impairment, or dementia.

The investigators will analyze the data to learn the correlations between eSAGE and gold standard neuropsychological testing designed to differentiate normal cognition from MCI and early dementia. The investigators will also find out whether the paper (SAGE) and electronic (eSAGE) versions of SAGE could be used interchangeably or not.

Addendum:

Subjects will be scheduled for a one time visit where they will be administered both the tablet eSAGE and the smartphone eSAGE. eSAGE tablet scores will be compared to eSAGE smartphone scores to determine if the two formats are equivalent to each other.

Study Design

Study Type:
Observational
Actual Enrollment :
69 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)
Study Start Date :
Jan 1, 2015
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 12, 2022

Arms and Interventions

Arm Intervention/Treatment
eSAGE score of 10

Participants who score a 10 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 11

Participants who score an 11 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 12

Participants who score a 12 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 13

Participants who score a 13 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 14

Participants who score a 14 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 15

Participants who score a 15 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 16

Participants who score a 16 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 17

Participants who score a 17 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 18

Participants who score a 18 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 19

Participants who score a 19 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 20

Participants who score a 20 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 21

Participants who score a 21 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 22

Participants who score a 22 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 9

Participants who score a 9 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 8

Participants who score an 8 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 6

Participants who score a 6 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 7

Participants who score a 7 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 5

Participants who score a 5 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 4

Participants who score a 4 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 3

Participants who score a 3 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

eSAGE score of 2

Participants who score a 2 on the eSAGE. Interventions include neuropsychological testing.

Behavioral: neuropsychological testing
standard neuropsychological testing including brief standardized assessments

Smartphone eSAGE score of 13

Participants who score a 13 on the smartphone eSAGE. Interventions include neuropsychological testing.

Behavioral: eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone

Smartphone eSAGE score of 14

Participants who score a 14 on the smartphone eSAGE. Interventions include neuropsychological testing.

Behavioral: eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone

Smartphone eSAGE score of 15

Participants who score a 15 on the smartphone eSAGE. Interventions include neuropsychological testing.

Behavioral: eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone

Smartphone eSAGE score of 16

Participants who score a 16 on the smartphone eSAGE. Interventions include neuropsychological testing.

Behavioral: eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone

Smartphone eSAGE score of 17

Participants who score a 17 on the smartphone eSAGE. Interventions include neuropsychological testing.

Behavioral: eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone

Smartphone eSAGE score of 18

Participants who score a 18 on the smartphone eSAGE. Interventions include neuropsychological testing.

Behavioral: eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone

Smartphone eSAGE score of 19

Participants who score a 19 on the smartphone eSAGE. Interventions include neuropsychological testing.

Behavioral: eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone

Smartphone eSAGE score of 20

Participants who score a 20 on the smartphone eSAGE. Interventions include neuropsychological testing.

Behavioral: eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone

Smartphone eSAGE score of 21

Participants who score a 21 on the smartphone eSAGE. Interventions include neuropsychological testing.

Behavioral: eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone

Smartphone eSAGE score of 22

Participants who score a 22 on the smartphone eSAGE. Interventions include neuropsychological testing.

Behavioral: eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone

Outcome Measures

Primary Outcome Measures

  1. eSAGE Score Compared to the Sum of the Neuropsychological Measures. [3 Hours]

    Analysis will consist of comparing the subject's scores on the SAGE in digital format to their neuropsychological test scores. This will be a composite score of the neuropsychological testing scores. The neuropsychological measures include: Boston Naming Test Wisconsin Card Sort Task (WCST) Hopkins Verbal Learning Test (HVLT) FAS verbal fluency task Wechsler Adult Intelligence Scale III (WAIS III) Letter-number and block design subtests Associations will be investigated using Spearman correlations.

Secondary Outcome Measures

  1. eSAGE Score Compared to the Paper SAGE Score [3 hours]

    The investigators will compare the subject's scores on the SAGE in digital format to their paper SAGE scores to determine if these two formats are equivalent to each other. Associations will be investigated using Spearman correlations.

  2. eSAGE Score Compared to the Mini-Mental State Examination (MMSE) Score [3 hours]

    The investigators will compare the eSAGE scores with the Mini-Mental State Examination (MMSE) scores. Associations will be investigated using Spearman correlations.

  3. eSAGE Score Compared to the Montreal Cognitive Assessment (MoCA) Score [3 hours]

    The investigators will compare the eSAGE scores with the Montreal Cognitive Assessment (MoCA) scores. Associations will be investigated using Spearman correlations.

  4. eSAGE Score Compared to the Boston Naming Test Score [3 hours]

    The investigators will compare the eSAGE scores to the Boston Naming Test score. The Boston Naming Test consists of 60 pictures of nouns that subjects must try to name. Associations will be investigated using Spearman correlations.

  5. eSAGE Score Compared to the Wisconsin Card Sort Task (WCST) Score [3 hours]

    The investigators will compare the eSAGE scores to the Wisconsin Card Sort Task (WCST) perseverative errors scores. Associations will be investigated using Spearman correlations.

  6. eSAGE Score Compared to the Hopkins Verbal Learning Test (HVLT) Score [3 hours]

    The investigators will compare the eSAGE scores to the Hopkins Verbal Learning Test (HVLT) total learning scores. Associations will be investigated using Spearman correlations. The investigators will also compare the eSAGE scores to the Hopkins Verbal Learning Test (HVLT) delayed recall scores. Associations will be investigated using Spearman correlations.

  7. eSAGE Score Compare to the FAS Verbal Fluency Task Score [3 hours]

    The investigators will compare the eSAGE scores to the FAS Verbal Fluency Task scores. Associations will be investigated using Spearman correlations.

  8. eSAGE Score Compared to the Wechsler Adult Intelligence Scale III (WAIS III) Letter-number Score [3 hours]

    The investigators will compare the eSAGE scores to the WAIS III Letter-number scores. The WAIS III Letter-number test asks subjects to recall a series of numbers in increasing order and letters in alphabetical order. Associations will be investigated using Spearman correlations.

  9. eSAGE Score Compared to the Wechsler Adult Intelligence Scale III (WAIS III) Block Design Score [3 hours]

    The investigators will compare the eSAGE scores to the WAIS III Block Design scores. The WAIS III Block Design requires the replication of red and white designs using three-dimensional colored blocks. Associations will be investigated using Spearman correlations.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adults over 49 years old of either gender

  • Vision and hearing sufficient for compliance with tests

Exclusion Criteria:
  • Diagnosis by a physician of moderate or severe dementia

  • Intellectual disability

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Ohio State University Columbus Ohio United States 43221

Sponsors and Collaborators

  • Ohio State University
  • Brain Test, Inc.

Investigators

  • Principal Investigator: Douglas Scharre, M.D., Ohio State University

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Douglas Scharre, Professor, Ohio State University
ClinicalTrials.gov Identifier:
NCT02544074
Other Study ID Numbers:
  • 2014H0039
First Posted:
Sep 9, 2015
Last Update Posted:
May 26, 2022
Last Verified:
Apr 1, 2022
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail The eSAGE test is scored from 0-22 with 22 indicating a perfect score.
Arm/Group Title eSAGE Score of 2 eSAGE Score of 3 eSAGE Score of 4 eSAGE Score of 5 eSAGE Score of 6 eSAGE Score of 7 eSAGE Score of 8 eSAGE Score of 9 eSAGE Score of 10 eSAGE Score of 11 eSAGE Score of 12 eSAGE Score of 13 eSAGE Score of 14 eSAGE Score of 15 eSAGE Score of 16 eSAGE Score of 17 eSAGE Score of 18 eSAGE Score of 19 eSAGE Score of 20 eSAGE Score of 21 eSAGE Score of 22
Arm/Group Description Participants who score a 2 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 3 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 4 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 5 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 6 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 7 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score an 8 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 9 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 10 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score an 11 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 12 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 13 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 14 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 15 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 16 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 17 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 18 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 19 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 20 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 21 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 22 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments
Period Title: Overall Study
STARTED 1 1 1 1 4 1 2 4 6 2 2 3 4 5 5 8 6 3 4 3 3
COMPLETED 1 0 1 1 4 0 2 4 6 1 2 3 4 5 5 8 6 3 4 3 3
NOT COMPLETED 0 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0

Baseline Characteristics

Arm/Group Title eSAGE Score of 2 eSAGE Score of 3 eSAGE Score of 4 eSAGE Score of 5 eSAGE Score of 6 eSAGE Score of 7 eSAGE Score of 8 eSAGE Score of 9 eSAGE Score of 10 eSAGE Score of 11 eSAGE Score of 12 eSAGE Score of 13 eSAGE Score of 14 eSAGE Score of 15 eSAGE Score of 16 eSAGE Score of 17 eSAGE Score of 18 eSAGE Score of 19 eSAGE Score of 20 eSAGE Score of 21 eSAGE Score of 22 Total
Arm/Group Description Participants who score a 2 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 3 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 4 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 5 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 6 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 7 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score an 8 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 9 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 10 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score an 11 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 12 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 13 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 14 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 15 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 16 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 17 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 18 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 19 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 20 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 21 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 22 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Total of all reporting groups
Overall Participants 1 1 1 1 4 1 2 4 6 2 2 3 4 5 5 8 6 3 4 3 3 69
Age (Count of Participants)
<=18 years
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
Between 18 and 65 years
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
1
20%
1
20%
3
37.5%
0
0%
0
0%
0
0%
0
0%
1
33.3%
6
8.7%
>=65 years
1
100%
1
100%
1
100%
1
100%
4
100%
1
100%
2
100%
4
100%
6
100%
2
100%
2
100%
3
100%
4
100%
4
80%
4
80%
5
62.5%
6
100%
3
100%
4
100%
3
100%
2
66.7%
63
91.3%
Sex: Female, Male (Count of Participants)
Female
0
0%
0
0%
0
0%
1
100%
3
75%
0
0%
0
0%
3
75%
4
66.7%
1
50%
2
100%
2
66.7%
2
50%
4
80%
2
40%
7
87.5%
3
50%
2
66.7%
3
75%
2
66.7%
3
100%
44
63.8%
Male
1
100%
1
100%
1
100%
0
0%
1
25%
1
100%
2
100%
1
25%
2
33.3%
1
50%
0
0%
1
33.3%
2
50%
1
20%
3
60%
1
12.5%
3
50%
1
33.3%
1
25%
1
33.3%
0
0%
25
36.2%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
Asian
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
1
20%
0
0%
0
0%
0
0%
1
33.3%
0
0%
0
0%
0
0%
2
2.9%
Native Hawaiian or Other Pacific Islander
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
Black or African American
0
0%
0
0%
0
0%
0
0%
1
25%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
2
40%
1
20%
1
12.5%
0
0%
0
0%
0
0%
0
0%
0
0%
5
7.2%
White
1
100%
1
100%
1
100%
1
100%
3
75%
1
100%
2
100%
3
75%
6
100%
2
100%
2
100%
3
100%
4
100%
2
40%
4
80%
7
87.5%
6
100%
2
66.7%
3
75%
3
100%
3
100%
60
87%
More than one race
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
Unknown or Not Reported
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
1
25%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
0
0%
1
25%
0
0%
0
0%
2
2.9%

Outcome Measures

1. Primary Outcome
Title eSAGE Score Compared to the Sum of the Neuropsychological Measures.
Description Analysis will consist of comparing the subject's scores on the SAGE in digital format to their neuropsychological test scores. This will be a composite score of the neuropsychological testing scores. The neuropsychological measures include: Boston Naming Test Wisconsin Card Sort Task (WCST) Hopkins Verbal Learning Test (HVLT) FAS verbal fluency task Wechsler Adult Intelligence Scale III (WAIS III) Letter-number and block design subtests Associations will be investigated using Spearman correlations.
Time Frame 3 Hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title eSAGE Score Compared to the Sum of Neuropsychological Measures
Arm/Group Description Analysis will consist of comparing the subject's scores on the SAGE in digital format to their neuropsychological test scores. This will be a composite score of the neuropsychological testing scores. The neuropsychological measures include: Boston Naming Test Wisconsin Card Sort Task (WCST) Hopkins Verbal Learning Test (HVLT) FAS verbal fluency task Wechsler Adult Intelligence Scale III (WAIS III) Letter-number and block design subtests Associations will be investigated using Spearman correlations.
Measure Participants 66
Number [spearman rank correlation]
0.7292
2. Secondary Outcome
Title eSAGE Score Compared to the Paper SAGE Score
Description The investigators will compare the subject's scores on the SAGE in digital format to their paper SAGE scores to determine if these two formats are equivalent to each other. Associations will be investigated using Spearman correlations.
Time Frame 3 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title eSAGE Score Compared to the Paper SAGE Score
Arm/Group Description The investigators will compare the subject's scores on the SAGE in digital format to their paper SAGE scores to determine if these two formats are equivalent to each other. Associations will be investigated using Spearman correlations.
Measure Participants 66
Number [spearman rank correlation]
0.8824
3. Secondary Outcome
Title eSAGE Score Compared to the Mini-Mental State Examination (MMSE) Score
Description The investigators will compare the eSAGE scores with the Mini-Mental State Examination (MMSE) scores. Associations will be investigated using Spearman correlations.
Time Frame 3 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title eSAGE Score Compared to the Mini-Mental State Exam Score
Arm/Group Description The investigators will compare the eSAGE scores with the Mini-Mental State Examination (MMSE) scores. Associations will be investigated using Spearman correlations.
Measure Participants 66
Number [spearman rank correlation]
0.6711
4. Secondary Outcome
Title eSAGE Score Compared to the Montreal Cognitive Assessment (MoCA) Score
Description The investigators will compare the eSAGE scores with the Montreal Cognitive Assessment (MoCA) scores. Associations will be investigated using Spearman correlations.
Time Frame 3 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title eSAGE Score Compared to the MoCA Score
Arm/Group Description The investigators will compare the eSAGE scores with the Montreal Cognitive Assessment (MoCA) scores. Associations will be investigated using Spearman correlations.
Measure Participants 66
Number [spearman rank correlation]
0.7577
5. Secondary Outcome
Title eSAGE Score Compared to the Boston Naming Test Score
Description The investigators will compare the eSAGE scores to the Boston Naming Test score. The Boston Naming Test consists of 60 pictures of nouns that subjects must try to name. Associations will be investigated using Spearman correlations.
Time Frame 3 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title eSAGE Score Compared to the Boston Naming Test Score
Arm/Group Description The investigators will compare the eSAGE scores to the Boston Naming Test scores. Associations will be investigated using Spearman correlations.
Measure Participants 66
Number [spearman rank correlation]
0.3487
6. Secondary Outcome
Title eSAGE Score Compared to the Wisconsin Card Sort Task (WCST) Score
Description The investigators will compare the eSAGE scores to the Wisconsin Card Sort Task (WCST) perseverative errors scores. Associations will be investigated using Spearman correlations.
Time Frame 3 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title eSAGE Score Compared to the WCST Score
Arm/Group Description The investigators will compare the eSAGE scores to the Wisconsin Card Sort Task (WCST) perseverative errors scores. Associations will be investigated using Spearman correlations.
Measure Participants 66
Number [spearman rank correlation]
0.4596
7. Secondary Outcome
Title eSAGE Score Compared to the Hopkins Verbal Learning Test (HVLT) Score
Description The investigators will compare the eSAGE scores to the Hopkins Verbal Learning Test (HVLT) total learning scores. Associations will be investigated using Spearman correlations. The investigators will also compare the eSAGE scores to the Hopkins Verbal Learning Test (HVLT) delayed recall scores. Associations will be investigated using Spearman correlations.
Time Frame 3 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title eSAGE Score Compared to the HVLT Total Learning Score eSAGE Score Compared to the HVLT Delayed Recall Score
Arm/Group Description The investigators will compare the eSAGE scores to the Hopkins Verbal Learning Test (HVLT) total learning scores. Associations will be investigated using Spearman correlations. The investigators will compare the eSAGE scores to the Hopkins Verbal Learning Test (HVLT) delayed recall scores. Associations will be investigated using Spearman correlations.
Measure Participants 66 66
Number [spearman rank correlation]
0.6045
0.4866
8. Secondary Outcome
Title eSAGE Score Compare to the FAS Verbal Fluency Task Score
Description The investigators will compare the eSAGE scores to the FAS Verbal Fluency Task scores. Associations will be investigated using Spearman correlations.
Time Frame 3 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title eSAGE Score Compared to the FAS Verbal Fluency Task Score
Arm/Group Description The investigators will compare the eSAGE scores to the FAS Verbal Fluency Task scores. Associations will be investigated using Spearman correlations.
Measure Participants 66
Number [spearman rank correlation]
0.3210
9. Secondary Outcome
Title eSAGE Score Compared to the Wechsler Adult Intelligence Scale III (WAIS III) Letter-number Score
Description The investigators will compare the eSAGE scores to the WAIS III Letter-number scores. The WAIS III Letter-number test asks subjects to recall a series of numbers in increasing order and letters in alphabetical order. Associations will be investigated using Spearman correlations.
Time Frame 3 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title eSAGE Score Compared to the WAIS III Letter-number Score
Arm/Group Description The investigators will compare the eSAGE scores to the WAIS III Letter-number scores. Associations will be investigated using Spearman correlations.
Measure Participants 66
Number [spearman rank correlation]
0.5349
10. Secondary Outcome
Title eSAGE Score Compared to the Wechsler Adult Intelligence Scale III (WAIS III) Block Design Score
Description The investigators will compare the eSAGE scores to the WAIS III Block Design scores. The WAIS III Block Design requires the replication of red and white designs using three-dimensional colored blocks. Associations will be investigated using Spearman correlations.
Time Frame 3 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title eSAGE Score Compared to the WAIS III Block Design Score
Arm/Group Description The investigators will compare the eSAGE scores to the WAIS III Block Design scores. Associations will be investigated using Spearman correlations.
Measure Participants 66
Number [spearman rank correlation]
0.5774

Adverse Events

Time Frame Adverse event data was collected for 1 day, the day of the study visit.
Adverse Event Reporting Description
Arm/Group Title eSAGE Score of 2 eSAGE Score of 3 eSAGE Score of 4 eSAGE Score of 5 eSAGE Score of 6 eSAGE Score of 7 eSAGE Score of 8 eSAGE Score of 9 eSAGE Score of 10 eSAGE Score of 11 eSAGE Score of 12 eSAGE Score of 13 eSAGE Score of 14 eSAGE Score of 15 eSAGE Score of 16 eSAGE Score of 17 eSAGE Score of 18 eSAGE Score of 19 eSAGE Score of 20 eSAGE Score of 21 eSAGE Score of 22
Arm/Group Description Participants who score a 2 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 3 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 4 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 5 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 6 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 7 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score an 8 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 9 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 10 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score an 11 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 12 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 13 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 14 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 15 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 16 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 17 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 18 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 19 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 20 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 21 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments Participants who score a 22 on the eSAGE. Interventions include neuropsychological testing. neuropsychological testing: standard neuropsychological testing including brief standardized assessments
All Cause Mortality
eSAGE Score of 2 eSAGE Score of 3 eSAGE Score of 4 eSAGE Score of 5 eSAGE Score of 6 eSAGE Score of 7 eSAGE Score of 8 eSAGE Score of 9 eSAGE Score of 10 eSAGE Score of 11 eSAGE Score of 12 eSAGE Score of 13 eSAGE Score of 14 eSAGE Score of 15 eSAGE Score of 16 eSAGE Score of 17 eSAGE Score of 18 eSAGE Score of 19 eSAGE Score of 20 eSAGE Score of 21 eSAGE Score of 22
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/4 (0%) 0/1 (0%) 0/2 (0%) 0/4 (0%) 0/6 (0%) 0/2 (0%) 0/2 (0%) 0/3 (0%) 0/4 (0%) 0/5 (0%) 0/5 (0%) 0/8 (0%) 0/6 (0%) 0/3 (0%) 0/4 (0%) 0/3 (0%) 0/3 (0%)
Serious Adverse Events
eSAGE Score of 2 eSAGE Score of 3 eSAGE Score of 4 eSAGE Score of 5 eSAGE Score of 6 eSAGE Score of 7 eSAGE Score of 8 eSAGE Score of 9 eSAGE Score of 10 eSAGE Score of 11 eSAGE Score of 12 eSAGE Score of 13 eSAGE Score of 14 eSAGE Score of 15 eSAGE Score of 16 eSAGE Score of 17 eSAGE Score of 18 eSAGE Score of 19 eSAGE Score of 20 eSAGE Score of 21 eSAGE Score of 22
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/4 (0%) 0/1 (0%) 0/2 (0%) 0/4 (0%) 0/6 (0%) 0/2 (0%) 0/2 (0%) 0/3 (0%) 0/4 (0%) 0/5 (0%) 0/5 (0%) 0/8 (0%) 0/6 (0%) 0/3 (0%) 0/4 (0%) 0/3 (0%) 0/3 (0%)
Other (Not Including Serious) Adverse Events
eSAGE Score of 2 eSAGE Score of 3 eSAGE Score of 4 eSAGE Score of 5 eSAGE Score of 6 eSAGE Score of 7 eSAGE Score of 8 eSAGE Score of 9 eSAGE Score of 10 eSAGE Score of 11 eSAGE Score of 12 eSAGE Score of 13 eSAGE Score of 14 eSAGE Score of 15 eSAGE Score of 16 eSAGE Score of 17 eSAGE Score of 18 eSAGE Score of 19 eSAGE Score of 20 eSAGE Score of 21 eSAGE Score of 22
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/4 (0%) 0/1 (0%) 0/2 (0%) 0/4 (0%) 0/6 (0%) 0/2 (0%) 0/2 (0%) 0/3 (0%) 0/4 (0%) 0/5 (0%) 0/5 (0%) 0/8 (0%) 0/6 (0%) 0/3 (0%) 0/4 (0%) 0/3 (0%) 0/3 (0%)

Limitations/Caveats

The majority of the subjects were Caucasian and highly educated. Results may be limited based on where the patients were recruited and their range of cognitive abilities. The ADCS-ADL scale was used as self-report in subjects without a study partner.

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Douglas Scharre, MD
Organization The Ohio State University
Phone 614-293-4969
Email Doug.Scharre@osumc.edu
Responsible Party:
Douglas Scharre, Professor, Ohio State University
ClinicalTrials.gov Identifier:
NCT02544074
Other Study ID Numbers:
  • 2014H0039
First Posted:
Sep 9, 2015
Last Update Posted:
May 26, 2022
Last Verified:
Apr 1, 2022